Dr-Joshua-Muli

Position: Lecturer
Department: Zoological Sciences
Contact Address: P.O. Box 43844-00100, Nairobi, Kenya
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.
Area of Specialization:Immunology

View full CV 

 Publications

  • Sagini Nicah NS, Klika, KD, Orry A, Mutiso JM, Berger MR. (2020). Pancreatic adenocarcinoma cells express proteins with lectin-like properties, some of which are modulated by exposure to riproximin. Frontiers in Pharmacology, doi: 10.3389/fphar.2020.549804.
  • Mutiso JM, Georges RB, Saginin M, Berger MR (2019). Riproximin suppresses NF-κB and ligates FAS/CD95 receptor leading to apoptosis in MDA-MB-231 and SW-707 cancer cells. International Journal of Medical Research and Pharmaceutical Sciences 6(2): 1-14.
  • Njeru A, Mutiso J, Kimutai A, Mibei EK. (2019). Performance of Rapid Immunochromatographic Test on Malaria Infection Among Expectant Women in Kericho County, Kenya. European Scientific Journal 15: 330-342. No.6 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431.
  • Macharia JC, Mutiso JM, Gicheru MM, Ogwayo IO, Ngatiri GG. (2018). Kala-Azar And The Associated Factors Influencing Health Care Seeking Among The Residents Of Baringo County, Kenya. Researchjournali’s Journal of Public Health 4 (7): 1
  • Ogise J, Mumo R, Nyachieo A, , Mutiso J, Kamau J, Onkoba N. (2016). Adjuvants in malaria vaccine development strategies: a review. Pathogen & Infectious Disease 2016; 2: e1259. doi: 10.14800/pid.1259.
  • Gitonga CM, Mutiso JM, Gicheru MM. (2016). Performance of Widal Test and Stool Culture as Diagnostic Methods for Salmonella typhi Infection. The African Journal of Health Sciences 29 (3).
  • Mwololo SW, Mutiso JM, Macharia JC, Bourdichon AJ, Gicheru MM. (2015) In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis. Journal of Biomedical Research 29(3):214-223.
  • Mwangi JN, Ozwara HS, Mutiso JM, Gicheru MM(2015) Characterization of Tunga penetrans Antigens in Selected Epidemic Areas in Murang’a County in Kenya. PLoS Neglected Tropical Diseases 9(3): e0003517. doi:10.1371/journal.pntd.0003517.
  • Laban LT, Anjili CO, Mutiso JM, Ingonga J, Kiige SG, Ngedzo MM, Gicheru MM. (2015) Experimental therapeutic studies of Solanum aculeastrum Dunal. on Leishmania major infection in BALB/c mice. Iranian Journal of Basic Medical Sciences 18: 64-71.
  • Kiige SG, Mutiso JM, Laban LT, Khayeka-Wandabwa C, Anjili CO, Ingonga J, Gicheru MM. (2014). F1 Cross-Breed Between Susceptible BALB/c and Resistant Swiss mice Infected with Leishmania major Exhibit an Intermediate Phenotype for Lesion Sizes and Type 1 Cytokines but Show Low Level of Total IgG Antibodies. Scandinavian Journal of Immunology 79: 283–291.
  • Mutiso JM, Macharia JC, Gicheru MM, Ozwara H. (2013). Immunology of leishmaniasis. Science Parasitology 14(2):51-61.
  • Mutiso JM, Macharia JC, Kiio MN, Mucheru PM, Onkoba WN, Maloba FC, Gicheru MM. (2013). Leishmania parasite specific CD4+ synergizes and correlates positively with CD8+ T cells in the production of gamma interferon following immunization of the vervet monkey (Chlorocebus aethiops) model. Science Parasitology 14(1):7-19. Mutiso JM, Macharia JC, Kiio MN,
  • Ichagichu JM, Rikoi H, Gicheru MM (2013) Development of Leishmania vaccines: predicting the future from past and present experience. Journal of Biomedical Research 27(2): 85-102.
  • Mutiso JM, Macharia JC, Taracha E, Gicheru MM (2012) Immunization with Leishmania vaccine-Alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model. Scandinavian Journal of Immunology 76: 471-477.
  • Mutiso JM, Macharia JC, Taracha E, Gicheru MM (2012) Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops). Journal of Biomedical Research 26(1):8-16.
  • Mutiso JM, Macharia JC, Taracha E, Wafula K, Rikoi H, Gicheru MM (2012) Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants. Revista do Instituto de Medicina Tropical de São Paulo 54(1):37-41.
  • Mutiso JM, Macharia JC, Barasa M, Taracha E, Bbourdichon AJ, Gicheru MM (2011) In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice. Revista do Instituto de Medicina Tropical de São Paulo 53(3):129-132.
  • Mutiso JM, Macharia JC, Mutisya RM, Taracha E (2010) Subcutaneous immunization against Leishmania major infection in mice: Efficacy of formalin-killed promastigotes combined with adjuvants. Revista do Instituto de Medicina Tropical de São Paulo 52(2):95-100.
  • Mutiso JM, Macharia JC, Kariuki TM, Gicheru MM (2009) Montanide ISA 720 is more effective than BCG as an adjuvant for Leishmania killed vaccine in BALB/c mice. International Journal of Integrative Biology 7(2): 107-116.
    Curriculum vitae Joshua MUTISO Page 7 of 7
  • Mutiso JM, Macharia JC, Gicheru MM (2010) A review of adjuvants for Leishmania vaccine candidates. Journal of Biomedical Research 24(1): 16-25.
    Barasa M, Mwangi I, Mutiso JM, Kagasi AE, Ozwara SH, Gicheru MM (2010) Plasmodium knowlesi H strain pregnancy malaria immune responses in Olive baboons (Papio anubis). International Journal of Integrative Biology 10(1): 54-58.
    ______________________________________________________________________________